Abilify
Abilify is a drug used to treat schizophrenia and belongs to a class of drugs known as typical anti psychotics. Recent findings have shown drugs in its class, including Zyprexa, can increase a patient's chances of diabetes over time.
On April 13th 2004, the FDA advised Bristol-Meyer-Squibb, the makers of the drug, to notify healthcare providers of a revised label placed on the drug to warn of this potential increased risk. Abilify lawyers specialize in assisting users of the drug who consumed it before the relabeling.
If you or a loved one has suffered an injury, illness or death, that seems to have been someone else's fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Links on the Web
 Bloglines Search: "Abilify"Article Search on Abilify |
| Sun, 11 May 2008 15:04:00 GMT Should kids get these drugs? Plan likely to increase scrutiny of... Theyre sold under the names Zyprexa, Geodon, Risperdal, Abilify, Seroquel, Clozaril and Invega. The... Click here to read this Dangerous Drugs - Abilify news article. |
| Sun, 11 May 2008 06:41:00 GMT Abilify Gets Expanded Label Abilify has been approved as a monotherapy for the treatment Bipolar I... Click here to read this Dangerous Drugs - Abilify news article. |
| Fri, 9 May 2008 15:51:00 GMT FDA OKs Abilify for secondary use against bipolar disorder ...said Thursday federal regulators expanded approval for Abilify to aid with the treatment of bipolar disorder. Click here to read this Dangerous Drugs - Abilify news article. |
| Fri, 9 May 2008 13:02:00 GMT FDA Approves Bristol-Myers Abilify For Secondary Use Against Bipolar (NYE: BMY) and Japanese partner Otsuka Pharmaceutical Co. for Abilify to aid with the treatment of bipolar disorder. Click here to read this Dangerous Drugs - Abilify news article. |
| Fri, 9 May 2008 12:59:00 GMT FDA Approves Bristol-Myers Abilify For Secondary Use Against Bipolar... __ __ 2008-05-09 12:59:00 FDA Approves Bristol-Myers Abilify For Secondary Use Against Bipolar Disorder... Click here to read this Dangerous Drugs - Abilify news article. |
| Thu, 8 May 2008 23:07:00 GMT FDA OKs Abilify for secondary use against bipolar disorder ...said Thursday federal regulators expanded approval for Abilify to aid with the treatment of bipolar disorder. Click here to read this Dangerous Drugs - Abilify news article. |
